Browsing by Author Toner, Guy C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2014Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)Boland, Amy; Chatfield, Mark; Gebski, Val; Grimison, Peter; Houghton, Baerin; Stockler, Martin; et al, Various; Friedlander, Michael; Gruney, H; Kichenadasse, G; Lewis, Craig; Rosenthal, M; Singhal, N; Thomson, D B; Toner, Guy C.; Vasey, P; Wong, S; Northern Clinical School: Medicine; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAccelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Annals of Oncology, vol.25, 1, 2014,pp 143-148
2010Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized TrialBoland, Amy L.; Boyer, Michael; Gebski, Val; Grimison, Peter; Gurney, Howard; Simes, Robert John; Stockler, Martin; Craft, Paul; Harvey, V; Levi, John; Lewis, Craig; Olver, Ian N; Thomson, Damien; Toner, Guy C.; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial, Journal of the National Cancer Institute, vol.102, 16, 2010,pp 1253-1262
2005Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma.Joshua, A; Kefford, Richard (Rick); Millward, Michael; Aamdal, Steinar; Hersey, Peter; Lynch, Kevin; Thomson, Damien; Toner, Guy C.; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium Institute; MedicineMulti-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma., Investigational New Drugs, vol.23,(3),2005,pp 253-256
2009An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate CancerBoyer, Michael; Gurney, Howard; Davis, Ian; Kotasek, Dusan; Pezaro, Carmel; Rosenthal, Mark; Soloman, Benjamin; Toner, Guy C.; Underhill, Craig; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead)An Open-Label, Single-Arm Phase Two Trial of Gefitinib in Patients With Advanced or Metastatic Castration-Resistant Prostate Cancer, American Journal of Clinical Oncology, vol.32, 4,pp 338-341
2013Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancerChatfield, Mark; Grimison, Peter; Houghton, Baerin; Stockler, Martin; Davis, Ian; Hovey, E.; Martin, Jarad; Toner, Guy C.; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePatterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer, BJU International, vol.112, 2, 2013,pp E35-E43
2002Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibodiesClarke, Stephen; Millward, Michael; Ackland, Stephen P.; Garg, M. B.; Rischin, D.; Smith, J.; Toner, Guy C.; Zalcberg, John; Concord Clinical School: ANZAC Research Institute; MedicinePhase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibodies, Annals of Oncology, vol.13,(11),2002,pp 1810-1818
2014Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyBoland, Amy; Fournier, Marion; Grimison, Peter; McDonald, Angus; O'Carrigan, Brent; Stockler, Martin; Clingan, P; Davis, I D; Hanning, F; Olver, Ian; Singhal, N; Thomson, D B; Toner, Guy C.; Underhill, Craig; Whitford, Hayley; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreTestosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study, Internal Medicine Journal, vol.44, 8, 2014,pp 813-817